EUVIMEDAtrasti EUVIMED
Crossref

Development and validation of machine learning models for predicting muscle-invasive bladder cancer

Batu Akalin, Akif Erbin, Onuralp Nisli, Halil Canat

Canadian Urological Association Journal · 2026-11-20 · 21 (3)

DOI: 10.5489/cuaj.9728 ↗

At a glance

Journal article in Canadian Urological Association Journal, published online on 2026-11-20. Written by Batu Akalin and 3 co-authors.

SantraukaBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Introduction

We aimed to develop and validate machine learning (ML)-based predictive models for the preoperative differentiation of muscle-invasive bladder cancer (MIBC) from non-muscle-invasive bladder cancer (NMIBC) using routinely available clinical and laboratory data, and to compare their diagnostic performance with the multiparametric magnetic resonance imaging (mpMRI)-based Vesical Imaging-Reporting and Data System (VI-RADS).

Methods

A total of 26 demographic, clinical, and biochemical variables were used to develop supervised ML models. Logistic regression, random forest, support vector machine, XGBoost, and LightGBM algorithms were trained to predict pathologic muscle invasion. The dataset was randomly divided into training (80%) and independent test (20%) cohorts. Model discrimination was evaluated using the area under the receiver operating characteristic curve (AUC). The performance of ML models was compared with a VI-RADS-based logistic regression model using the DeLong test, and model calibration was assessed using Brier scores.

Results

A total of 428 patients were included, comprising 317 with NMIBC and 111 with MIBC. In the independent test cohort, both the VI-RADS–based logistic regression model and the LightGBM model demonstrated high discriminative performance, with AUC values of approximately 0.93. Among ML methods, LightGBM showed the best overall performance. SMOTE improved sensitivity in most models, while calibration remained acceptable. DeLong analysis showed no significant difference between the LightGBM and VI-RADS models (p=0.49).

Conclusions

ML models based on routinely available clinical and laboratory variables achieved high diagnostic accuracy for predicting MIBC. The LightGBM model demonstrated performance comparable to the VI-RADS-based approach in the independent validation cohort and may serve as a complementary tool for risk stratification, particularly in settings where access to mpMRI is limited.

Cite

APA

Akalin, B., Erbin, A., Nisli, O., & Canat, H. (2026). Development and validation of machine learning models for predicting muscle-invasive bladder cancer. Canadian Urological Association Journal, 21(3). https://doi.org/10.5489/cuaj.9728

Vancouver

Akalin B, Erbin A, Nisli O, Canat H. Development and validation of machine learning models for predicting muscle-invasive bladder cancer. Canadian Urological Association Journal. 2026;21(3). doi:10.5489/cuaj.9728

BibTeX
@article{Akalin2026,
  author = {Akalin, Batu and Erbin, Akif and Nisli, Onuralp and Canat, Halil},
  title = {Development and validation of machine learning models for predicting muscle-invasive bladder cancer},
  journal = {Canadian Urological Association Journal},
  year = {2026},
  volume = {21},
  number = {3},
  doi = {10.5489/cuaj.9728}
}
Start for free →